Apollo Medical Holdings, Inc.
NASDAQ:AMEH
40.82 (USD) • At close February 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,144.163 | 773.915 | 370.248 | 560.618 | 519.908 | 356.356 | 57.428 | 44.049 | 32.99 | 10.484 | 7.776 | 5.111 | 3.897 | 2.441 | 1.057 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 944.685 | 596.142 | 348.543 | 467.805 | 361.132 | 273.453 | 48.736 | 34.001 | 22.067 | 9.076 | 6.316 | 4.132 | 3.315 | 1.814 | 1.046 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 199.478 | 177.773 | 21.705 | 92.813 | 158.776 | 82.903 | 8.692 | 10.048 | 10.922 | 1.408 | 1.46 | 0.978 | 0.582 | 0.628 | 0.011 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.174 | 0.23 | 0.059 | 0.166 | 0.305 | 0.233 | 0.151 | 0.228 | 0.331 | 0.134 | 0.188 | 0.191 | 0.149 | 0.257 | 0.011 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 77.67 | 62.077 | 15.593 | 41.482 | 43.354 | 26.25 | 18.583 | 16.963 | 11.282 | 5.287 | 3.518 | 1.379 | 0.567 | 0.694 | 0.827 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 77.67 | 62.077 | 15.593 | 41.482 | 43.354 | 26.25 | 18.583 | 16.963 | 11.282 | 5.287 | 3.518 | 1.379 | 0.567 | 0.694 | 0.827 | 0.037 | 0.027 | 0.013 | 0.01 | 0.008 |
Other Expenses
| 3.944 | -3.75 | 7.694 | 3.03 | 1.622 | 0.168 | 0.015 | 0.239 | 0.003 | 0.05 | -0.037 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 95.213 | 79.594 | 15.619 | 58.399 | 66.545 | 45.325 | 19.229 | 17.314 | 11.617 | 5.318 | 3.538 | 1.392 | 0.578 | 0.73 | 0.847 | 0.037 | 0.027 | 0.013 | 0.01 | 0.008 |
Operating Income
| 104.265 | 98.179 | 6.086 | 32.42 | 88.432 | 35.146 | -10.537 | -7.266 | -0.694 | -3.91 | -2.078 | -0.413 | 0.004 | -0.103 | -0.836 | -0.037 | -0.027 | -0.013 | -0.01 | -0.008 |
Operating Income Ratio
| 0.091 | 0.127 | 0.016 | 0.058 | 0.17 | 0.099 | -0.183 | -0.165 | -0.021 | -0.373 | -0.267 | -0.081 | 0.001 | -0.042 | -0.79 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -11.705 | -16.608 | 4.903 | -5.865 | -10.302 | 11.198 | 1.89 | -0.436 | 0.837 | 0.05 | -5.891 | 0.003 | -0.032 | -0.04 | -0.046 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax
| 86.616 | 77.748 | 8.868 | 25.84 | 82.627 | 49.711 | -8.729 | -8.244 | -1.184 | -4.539 | -8.9 | -0.715 | -0.155 | -0.195 | -0.891 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax Ratio
| 0.076 | 0.1 | 0.024 | 0.046 | 0.159 | 0.139 | -0.152 | -0.187 | -0.036 | -0.433 | -1.144 | -0.14 | -0.04 | -0.08 | -0.843 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 40.875 | 31.693 | 9.182 | 8.167 | 22.36 | 3.887 | -0.047 | -0.071 | 0.164 | 0.02 | 0.005 | 0.006 | 0.002 | 0.001 | 0.001 | 0.037 | 0.027 | 0.013 | 0.01 | 0.008 |
Net Income
| 45.171 | 68.923 | -23.752 | 14.116 | 10.835 | 25.802 | -8.97 | -9.344 | -1.803 | -5.02 | -8.905 | -0.72 | -0.156 | -0.196 | -0.892 | -0.037 | -0.027 | -0.013 | -0.01 | -0.008 |
Net Income Ratio
| 0.039 | 0.089 | -0.064 | 0.025 | 0.021 | 0.072 | -0.156 | -0.212 | -0.055 | -0.479 | -1.145 | -0.141 | -0.04 | -0.08 | -0.843 | 0 | 0 | 0 | 0 | 0 |
EPS
| 1 | 1.57 | -0.65 | 0.41 | 0.33 | 0.8 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.057 | -0.074 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
EPS Diluted
| 0.99 | 1.52 | -0.63 | 0.39 | 0.29 | 0.8 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.057 | -0.074 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
EBITDA
| 133.35 | 111.404 | 40.27 | 50.847 | 106.29 | 56.724 | -9.877 | -6.676 | -0.357 | -3.829 | -2.095 | -0.398 | 0.015 | -0.067 | -0.816 | -0.037 | -0.027 | -0.013 | -0.01 | -0.008 |
EBITDA Ratio
| 0.117 | 0.144 | 0.109 | 0.091 | 0.204 | 0.159 | -0.172 | -0.152 | -0.011 | -0.365 | -0.269 | -0.078 | 0.004 | -0.027 | -0.772 | 0 | 0 | 0 | 0 | 0 |